We are inventing novel technologies to treat advanced cancers and to detect disease at early stages. We are a young bioengineering laboratory that develops new nanotechnologies, including nanomedicines—tiny particles that target drugs to tumor sites, and nanosensors—tiny devices that detect markers of disease. Please check out our recent innovations using the “Learn more” button below…
Daniel A. Heller, PhD
Research FocusChemist Daniel Heller focuses on biomaterials and nanoscale engineering for molecular sensors and targeted therapeutics.
EducationPhD, University of Illinois at Urbana-Champaign
- TV Galassi, PV Jena, J Shah, G Ao, E Molitor, Y Bram, A Frankel, J Park, J Jessurun, DS Ory, A Haimovitz-Friedman, D Roxbury, J Mittal, M Zheng, R E Schwartz, DA Heller*. “An Optical Nanoreporter of Endolysosomal Lipid Accumulation Reveals Enduring Effects of Diet on Hepatic Macrophages In Vivo.” Science Translational Medicine 10 (2018) eaar2680.
- Y Shamay, J Shah, DF Tschaharganeh, D Roxbury, J Budhathoki-Uprety, M Işık, A Mizrachi, K Nawaly, JL Sugarman, E Baut, MR Neiman, DC Johnson, R Sridharan, KL Chu, VK Rajasekhar, JD Chodera, SW Lowe, DA Heller*, “Quantitative Self-Assembly Prediction Yields Targeted Nanomedicines” Nature Materials (2018)
- NSF CAREER Award (2018)
- Pershing Square Sohn Prize for Young Innovators in Cancer Research (2017)
- NIH Director’s New Innovator Award (2012)
- Damon Runyon Cancer Research Foundation Postdoctoral Fellowship (2010)
- Beckman Institute Graduate Fellowship (2006)